Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema

International Angiology

Volumn 31, Issue 4, 2012, Pages 310-315

  Allaert, F A ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Drug therapy; Edema; Venous insufficiency

Indexed keywords

ANTIINFLAMMATORY AGENT; DIOSMIN; MICRONISED PURIFIED FLAVONOID FRACTION; MONOXERUTIN; PLACEBO; RUSCUS EXTRACT; UNCLASSIFIED DRUG;

ANKLE CIRCUMFERENCE; ANKLE EDEMA; ANTHROPOMETRIC PARAMETERS; ARTICLE; DRUG EFFICACY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANKLE; CARDIOVASCULAR AGENTS; EDEMA; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VEINS; VENOUS INSUFFICIENCY;

EID: 84867591212     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Allaert FA, Cazaubon M, Vin F, Ionescu L. La première consultation pour maladie veineuse chez l'angiologue/phlébologue (Etude Privila). Angéiologie 2006;58:37-43 (Pubitemid 44622788)
2. Carpentier PH, Maricq HR, Biro C, Ponçot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg 2004;40:650-9. (Pubitemid 39328084)
3. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15:175-84. (Pubitemid 40269465)
4. Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology 2008;23:103-11.
5. Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 2008;27:1-59. (Pubitemid 351523668)
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al.; for the GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924.
7. Elbaz C, Nebot N, Reinharez D. Insuffisance veineuse des membres inférieurs. Etude contr™lée de l'action du Cyclo 3. Phlébologie 1976;29:77-84.
8. Bergstein NAM. Clinical study on the efficacy of O-(β-Hydroxyethyl) Rutoside (HR) in varicosis of pregnancy. J Int Med Res 1975;3:189-93.
9. Sentou Y Double blind study of the activity of Cyclo 3® in man. Int Angio 1984;3:106-8.
10. Braun R, Hirche H, Van Laak HH. Treatment of venous insufficiency: a double-blind trial with phlebodril. Z Allgemeinmed 1985;61:309-13. (Pubitemid 15112548)
11. Capelli R, Nicora M, Di Petri T. Use of extract of ruscus aculeatus in venous disease in the lower limbs. Drugs Exp Clin Res 1988;14:277-83.
12. Tsouderos Y. Are the venoactive drugs properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Int Angiol 1989;8(Suppl 4):53-9. (Pubitemid 20126954)
13. Gilly R, Pillion G, Frileux C. Evaluation of a new venoactive micronized flavonoid fraction (S5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: A double-blind, placebo-controlled study. Phlebology 1994;9:67-70. (Pubitemid 24209803)
14. Amato C. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin. Angiology 1994;6:531-6. (Pubitemid 24179189)
15. Cloarec M, Clément R, Griton P. A double-blind trial of hydroxyethylrutosides in the treatment of symptoms and signs of chronic venous insufficiency. Phlebology 1996;11:76-82. (Pubitemid 26280591)
16. Olszewski W. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in Edema. Angiology 2000;51:25-9. (Pubitemid 30059048)
17. Amiel M, Barbe R, Revel D. Etude de la relation dose/effet de Daflon 500 mg par pléthysmographie chez l'homme. JIM 1987;85:16-88.
18. Paysant J, Sansilvestri-Morel P, Bouskela E, Verbeuren TJ. Les différents flavonoïdes de la fraction flavonoïque purifiée micronisée (Daflon 500mg) contribuent à normaliser la perméabilité au niveau de la microcirculation de la poche jugale de hamster. Int Angiol 2008;27:81-5.
19. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol 2003;22(3):250-62. (Pubitemid 37483695)
20. Pascarella L, Lulic D, Penn AH, Alsaigh T, Lee J, Shin H et al. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Eur J Vasc Endovasc Surg 2008;35:102-10. (Pubitemid 350235235)